Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
about
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsThe emerging roles of human tissue kallikreins in cancerAdvances in preclinical investigation of prostate cancer gene therapy.CD40-activated B cells induce anti-tumor immunity in vivo.Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.Dendritic cell-based immunotherapy for prostate cancer.Extracellular proteases as targets for drug developmentEvaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson diseaseThe immunotherapy of prostate and bladder cancer.Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.Trial watch: Dendritic cell-based interventions for cancer therapyAntiprotease therapy in cancer: hot or not?PSA-based vaccines for the treatment of prostate cancer.CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.Directing dendritic cell immunotherapy towards successful cancer treatment.Dendritic-cell vaccination for prostate cancer.Prostate cancer immunology - an update for Urologists.Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.Cellular immunotherapy of cancer: an overview and future directions.Dendritic cell immunotherapy.Dendritic Cell-Based Immunotherapy
P2860
Q24651090-40351C5D-A08F-497F-8F7B-EC0AAF17672EQ28290701-1CD65A7C-5A5B-45B5-9CF5-1A6D09358C8BQ33677054-C983238A-8907-4118-9BDF-DA08693F13FCQ33709425-C522E87A-0C22-4D6F-8C11-B9E549D0E1BAQ33872776-F050D7BC-1E67-4AF7-B508-2684D0F9AB63Q33886261-66D2E1C2-D7B2-42CF-9616-4DF07ED02E9AQ34284652-BFA94A6D-DF88-40C7-B741-CEB1C4212665Q35116202-0174E9FB-DD02-477F-A4F8-EB91BF207325Q35887768-B26E7643-2735-43F3-886E-ED74E647417AQ36249962-831254A9-1F10-44FF-B36E-F5D92A267318Q36258513-61CD0DEE-FDCC-4F9E-BE57-1145E90A8883Q36388529-6E1D1CDE-F6D8-4886-B8B0-B700DF81CD21Q36407244-572F4A54-904F-450F-B48F-C8D79F24ECB1Q36445536-97282B51-5A87-4FBE-A512-B9F5B218F765Q37336918-D3108767-BF51-46E8-9E25-C9A0E7251365Q37754014-869529D5-4077-43DF-8473-ECFFBB9AB41AQ37773277-4F372383-7576-4AE9-8DBD-531E31B05F0CQ37808756-A8CA2FB4-5A29-4544-AF85-3A2C5D66AA30Q38031280-353F1707-D463-4343-AEAC-67466204769BQ38212231-1575856D-8FE8-45CE-9BE2-873F4CB37511Q38673161-C591F5B5-5D56-47E0-AF4C-22DE918CDD27Q44483910-88401003-F2F1-4129-8213-B992C9F0D2CCQ58409682-B5B606E5-01BE-4609-A325-CF850DFDD60B
P2860
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
description
im Februar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 February 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2004
@uk
name
Vaccination of prostatectomize ...... sed with recombinant human PSA
@en
Vaccination of prostatectomize ...... sed with recombinant human PSA
@nl
type
label
Vaccination of prostatectomize ...... sed with recombinant human PSA
@en
Vaccination of prostatectomize ...... sed with recombinant human PSA
@nl
prefLabel
Vaccination of prostatectomize ...... sed with recombinant human PSA
@en
Vaccination of prostatectomize ...... sed with recombinant human PSA
@nl
P2093
P1476
Vaccination of prostatectomize ...... sed with recombinant human PSA
@en
P2093
Benoît Barrou
Gérard Benoît
Mahmoud Ouldkaci
Margarita Salcedo
Mats L Ericson
Nadège Bercovici
Nicolas Thiounn
Sudhanshu Agrawal
Séverine Massicard
P2888
P304
P356
10.1007/S00262-003-0451-2
P577
2004-02-04T00:00:00Z